Mantle Cell Lymphoma


CURE’s mantle cell lymphoma (MCL) page features the latest cancer news and updates on mantle cell lymphoma Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in mantle cell lymphoma.

Latest News

blood cancer cells floating. A novel CD NK therapy could benefit patients with lymphoma, CLL, SLL, mantle cell lymphoma, among others.
Cord Blood-Derived Treatment Shows Promise in Blood Cancer

January 25th 2024

A CAR NK therapy made from cord blood showed promising responses in patients with relapsed or refractory B-cell malignancies.

Target on a cancer cell
‘Remarkable’ Results from Tecartus in Patients With R/R MCL

January 4th 2024

target on cancer cell
Tecartus Induces Responses in Real-World Population of High-Risk R/R MCL

December 10th 2023

lymphoma cells
Encouraging Trial Results Announced for Breyanzi in Lymphoma Treatment

May 17th 2023

Everett, WA. USA - 08/24/2020: Imbruvica Ibrutinib a Modern Leukemia Cancer Treatment Therapy Drug | Image credit: © CLShelby
Pharma Companies Pull Imbruvica Indication for Marginal Zone and Mantle Cell Lymphoma

April 7th 2023

Video Series
Video Interviews

More News